Gタンパク質結合中のアデノシンA2A受容体の構成図を描く
Shuya Kate Huang1, Aditya Pandey2, Duy Phuoc Tran3
1Department of Chemistry, University of Toronto, UTM, 3359 Mississauga Road North, Mississauga, Ontario L5L 1C6, Canada.
Cell
|March 20, 2021
まとめ
フッ素NMRは,Gタンパク質と相互作用するアデノシンA2A受容体 (A2A R) の異なる機能状態を明らかにする. これは,リガンドとGタンパク質サブユニットが受容体シグナル伝達とアロステリーをどのように制御するかを明らかにします.
科学分野:
- 生物化学
- 構造生物学
- 薬理学について
背景:
- Gタンパク質結合受容体 (GPCR) は重要な膜タンパク質であり,薬物の標的である.
- GPCRシグナリングは,構造的方法によって容易に捕捉できない複雑な構成集合を含みます.
研究 の 目的:
- 19F NMRを用いて,Gタンパク質と複合したアデノシンA2A受容体 (A2A R) の機能的状態を定義する.
- A2A Rコンフォメーションダイナミクスにおけるリガンド,Gタンパク質,およびヌクレオチドの役割を調査する.
主な方法:
- フッ素核磁気共鳴スペクトル (19F NMR)
- 生物化学分析について
- コンピュータによる研究
主要な成果:
- 特定された非活性状態,Gタンパク質に結合した活性化中間体,および明確なヌクレオチドフリー状態.
- Gβγサブユニットは,リガンド依存性アロステリック伝播において重要であることが示された.
- 膜環境におけるA2A Rの構成集合を特徴づけている.
結論:
- GPCRの基礎信号伝達,有効性,先行結合,およびアロステリーを理解するためのメカニズム的基礎を提供した.
- GPCRの機能的動態を研究するための19F NMRの有用性を強調した.
関連する概念動画
Activation and Inactivation of G Proteins
8.6K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.6K
G-protein Coupled Receptors
128.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
128.1K
The Two-State Receptor Model
2.8K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.8K
G Protein-coupled Receptors
14.9K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.9K
GPCRs Regulate Adenylyl Cylase Activity
6.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.3K
Transducer Mechanism: G Protein–Coupled Receptors
3.2K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.2K


